Matthew Plunkett is VP at CTI BIOPHARMA CORP (CTIC). They have made 4 open-market trades across 1 company since 2014, most recently 2016-03-21.
CIK 0000891293
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CTIC | 526,210 | $4.8M |
Shares reported on the most recent Form 4, priced at the 2016-03-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTIC | SELL | 2016-03-04 | 2016-03-04 | $0.59 | $7K | -4.3% | -9.4% | -26.0% |
| CTIC | SELL · 10b5-1 | 2016-02-04 | 2016-02-05 | $1.16 | $12K | +55.5% | +56.3% | +15.6% |
| CTIC | SELL | 2016-01-04 | 2016-01-06 | $1.21 | $13K | -4.2% | -6.7% | -57.3% |
| CTIC | SELL · 10b5-1 | 2015-12-04 | 2015-12-04 | $1.00 | $9K | -2.5% | +1.7% | -50.6% |
| CTIC | SELL · 10b5-1 | 2015-11-04 | 2015-11-06 | $1.38 | $14K | -2.5% | +1.7% | -5.8% |
| CTIC | SELL · 10b5-1 | 2015-10-05 | 2015-10-07 | $1.52 | $15K | -2.5% | +1.7% | +5.0% |
| CTIC | SELL | 2015-09-29 | 2015-10-01 | $1.41 | $106K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-09-24 | 2015-09-25 | $1.57 | $119K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-09-04 | 2015-09-04 | $1.54 | $15K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-08-04 | 2015-08-06 | $1.85 | $18K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-07-06 | 2015-07-08 | $1.95 | $20K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-06-04 | 2015-06-05 | $2.06 | $21K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-05-04 | 2015-05-04 | $1.86 | $19K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-04-06 | 2015-04-08 | $1.88 | $31K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-03-23 | 2015-03-24 | $1.96 | $116K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-03-04 | 2015-03-06 | $2.41 | $29K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-02-04 | 2015-02-06 | $2.22 | $27K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2015-01-05 | 2015-01-07 | $2.36 | $28K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-12-04 | 2014-12-05 | $2.24 | $27K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-11-04 | 2014-11-06 | $2.39 | $29K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-10-06 | 2014-10-08 | $2.40 | $29K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-09-22 | 2014-09-24 | $2.56 | $265K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-08-04 | 2014-08-06 | $2.48 | $30K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-07-07 | 2014-07-09 | $2.89 | $35K | -2.5% | +1.7% | +1.7% |
| CTIC | SELL · 10b5-1 | 2014-06-04 | 2014-06-06 | $3.02 | $36K | -2.5% | +1.7% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.